Ebola Oral Drug Trial NV-387 Registered in DRC for Outbreak

NanoViricides announces Phase II clinical trial registration for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo amid the largest outbreak.

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand ...

SHELTON, CT / ACCESS Newswire / September 8, 2026 / , Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase ...